Veru to present at the h.c. wainwright global investment conference on may 24th 2022

Miami, may 17, 2022 (globe newswire) -- veru inc. (nasdaq: veru), a biopharmaceutical company focused on developing novel medicines for covid-19 and other viral and ards-related diseases and for the management of breast and prostate cancers, today announced that the company will present at the h.c. wainwright global investment conference. the presentation will be available through the conference on tuesday, may 24th at 11:30 am – 12:00 pm (eastern daylight time).
VERU Ratings Summary
VERU Quant Ranking